Most people who use psychedelics in naturalistic settings consider altered states of consciousness very or extremely important to the therapeutic effects (76%), yet a majority (61%) are moderately to extremely likely to try a non-hallucinogenic psychedelic analog for treating a mental health condition. Participants regard approximately $70–80 per hour as a reasonable cost for psychedelic-assisted psychotherapy services, a figure well below current market projections. The findings suggest that while the subjective experience is valued, openness to alternatives exists, and the perceived affordable price for treatment is lower than anticipated.
Most Canadians who have used psychedelics never discuss that use with their health care provider, even though a third use them to self-treat a health condition. In a survey of 2,384 adults, 81.2% had never talked about psychedelics with their primary clinician, only 4.4% used them with a therapist, and 3.6% in a clinical setting. Although 44.8% knew about substance testing services, only 42.4% of those had ever used them. People were more likely to discuss psychedelic use with their provider if they had a therapeutic motivation, were more inclined to seek therapist guidance, or identified as non-binary.